abstract |
The present invention relates to novel compounds of formula (I) which are AMP-protein kinase activators and which are useful for the treatment, prevention and suppression of diseases mediated by AMPK-activated protein kinases. The compounds of the invention are useful in the treatment of type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia and hypertension. □ |